Permanently Discontinued

BALMINIL EXPECTORANT (SUCROSE FREE)

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is BALMINIL EXPECTORANT (SUCROSE FREE) discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that BALMINIL EXPECTORANT (SUCROSE FREE) 100MG has been permanently discontinued (last updated May 28, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is BALMINIL EXPECTORANT (SUCROSE FREE) not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file4 products

Affected strength100MG

Last updated2025-05-28

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

EXPECTORANT COUGH FORMULA SYR 100MG/5ML

TANTA PHARMACEUTICALS INC

100MG · DIN 00813095

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

CALMYLIN EXPECTORANT SYR 100MG/5ML

TECHNILAB PHARMA INC.

100MG · DIN 00404691

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

BALMINIL EXPECTORANT LIQ 100MG/5ML

ROUGIER PHARMA DIVISION OF RATIOPHARM INC

100MG · DIN 00026794

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

GUAIFENESINE LIQ 100MG/5ML

ROUGIER PHARMA DIVISION OF RATIOPHARM INC

100MG · DIN 01928856

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

00609951

Strength

100MG

Dosage Form

SYRUP

Route

ORAL

Active Ingredient

GUAIFENESIN

Tier

Unrated

Last Updated

2025-05-28

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

DIN 00834319

3.5MG · DIN 02438399

0.5MG · DIN 02301407

100MG · DIN 02420155

200MG · DIN 02420163